ALGN
$176.12
Align Technology, Inc.
Recent News
Here's Why You Should Hold Cencora Stock in Your Portfolio for Now
Cencora's strong U.S. growth, MSO strategy, and raised outlook support long-term potential, but competition and customer losses remain key risks.
DraftKings, Eli Lilly downgraded: Wall Street's top analyst calls
DraftKings, Eli Lilly downgraded: Wall Street's top analyst calls
Is Align Technology Stock Outperforming the Nasdaq?
As Align Technology has outperformed the Nasdaq recently, analysts remain moderately optimistic about the stock’s prospects.
Here's Why You Should Hold DexCom Stock in Your Portfolio for Now
DXCM gains from CGM demand, Medicare coverage expansion and its new G7 15-day sensor, but rising competition and manufacturing investments may pressure margins.
Assessing Align Technology (ALGN) Valuation After Earnings Surprise And Institutional Buying
Align Technology (ALGN) has been back on investors’ radar after a 10.77% earnings surprise, 5.3% revenue growth in the latest quarter, and a sizable stake increase from Capital International Inc. CA. See our latest analysis for Align Technology. Despite the recent 1-day share price return decline of 1.61% and a 7-day share price return decline of 5.61%, Align’s earnings surprise, revenue growth and participation in SprintRay’s Midas World Tour have kept attention on its role in digital...